USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

USANA Health Sciences addresses challenges, eyes growth through cost management

USANA Health Sciences navigated a challenging operating environment by focusing on cost management, product demand trends, and growth strategies. Despite facing headwinds in China and Southeast Asia, the company remains resilient and poised for opportunities in new markets and acquisitions.

USANA Health Sciences reports solid Q1 results amid global challenges

USANA Health Sciences delivered strong Q1 results amidst global challenges, driven by robust demand for health products.
Strategic leadership transition and focus on cost management position the company for sustained growth and operational efficiency.
Opportunities in China market, new market launches, and enhanced customer engagement strategies offer avenues for future expansion.

USANA Health Sciences exceeds Q2 expectations, eyes India expansion

USANA Health Sciences delivered strong Q2 results with a focus on sustainable growth strategies and expansion into new markets. Challenges include tough year-over-year comparisons and cash flow impact from accrued liabilities.

USANA Health Sciences addresses challenges, eyes India expansion for growth

USANA Health Sciences navigated challenges in Q3 2023 with a focus on addressing operational hurdles and driving growth through strategic initiatives. The company's restructuring and expansion into India signal a commitment to long-term success and capitalizing on emerging opportunities.

USANA Health Sciences exceeds Q4 expectations, eyes global growth

USANA Health Sciences delivered strong performance in Q4 2023, driven by growth in Greater China and a solid financial position. While facing challenges such as currency fluctuations and market-specific issues, the company is well-positioned to capitalize on opportunities through strategic initiatives and market tailoring. By focusing on sustainable growth and innovation, USANA aims to further strengthen its market presence and drive profitability.

USANA Health Sciences reports mixed Q1 results, eyes growth strategies

USANA Health Sciences faced mixed results in Q1 2024, with Mainland China driving growth while other markets struggled. The company is addressing challenges through market-specific incentives and focusing on future strategies like product development and localization.

USANA Health Sciences adapts to market challenges with strategic focus

USANA Health Sciences navigated macroeconomic challenges by implementing strategic initiatives and restructuring its commercial team.
The company's focus on product innovation, market expansion into India, and leadership additions signal a commitment to sustainable success.
While facing challenges in market conditions, USANA aims to leverage opportunities like M&A activities and accelerated product development for growth.

USANA Health Sciences adapts strategies to drive growth amid challenges

USANA Health Sciences faced challenges in Q3 with lower-than-expected net sales, particularly in China, but is implementing strategies to boost performance.
The company's strengths in product innovation, streamlined development processes, and strong product lineup position it well for future growth.
Addressing challenges such as decreased average spend and revised guidance presents opportunities for USANA to enhance revenue and market presence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SALT LAKE CITY , Nov. 12, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in nutrition, was recently awarded Manufacturer of the Year for the third consecutive year by the Utah Manufacturers Association in the "mega-sized (500+ employees) companies" category. To learn more about USANA and its commitment to quality, please visit USANA.com.

USANA Named Top Manufacturer in Utah for Third Time

SALT LAKE CITY , Nov. 1, 2024 /PRNewswire/ -- This November, a multinational leader is encouraging people everywhere to celebrate National Gratitude Month and experience the profound impact gratitude has on health and happiness. From enhancing psychological well-being to boosting physical health, gratitude has a transformative effect that can change lives in deeply meaningful ways.

USANA Executive Chairman Kevin Guest Celebrates Gratitude Month

USANA Health Sciences, Inc. (NYSE:USNA ) Q3 2024 Earnings Call Transcript October 23, 2024 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President and CEO Douglas Hekking - CFO Brent Neidig - CCO Conference Call Participants Anthony Lebiedzinski - Fidelity Sidoti Linda Bolton Weiser - Davidson Operator Good day, and welcome to today's Usana Health Sciences Third Quarter Earnings Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode.

USANA Health Sciences, Inc. (USNA) Q3 2024 Earnings Call Transcript

USANA Health Sciences (USNA) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.59 per share a year ago.

USANA Health Sciences (USNA) Q3 Earnings Surpass Estimates

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 28, 2024. Key Financial & Operating Results Third quarter net sales were $200 million versus $213 million during Q3 2023. Third quarter diluted EPS was $0.56 as compared with $0.59 during Q3 2023. Company updates fiscal year 2024 net sales and diluted EPS outlook to approximately $850 million and $2.45, respectively (previously $850 million.

USANA Health Sciences Reports Third Quarter 2024 Results

Arch Resources

Buckle

Cal-Maine Foods

Mr. Cooper Group Inc

Gogo

Warrior Met Coal

Meritage Homes

TRI Pointe Group

Virtu Financial

David Trainer explains how New Constructs incorporates decades of information buried in companies' financial statement notes, for “better” calculations of returns on invested capital

10 small-cap stocks selected by digging deep for quality

SALT LAKE CITY , Oct. 10, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. is proud to announce that the Prescribers' Digital Reference® (PDR) has recently included 11 of USANA's products to their list of trusted drugs and supplements. This recognition adds further credibility to the world-renowned quality of USANA's products while placing supplemental facts directly in the hands of prescribers.

11 USANA Products Now Listed on Prestigious Prescribers' Digital Reference®

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2024 results will be released after the close of market on Tuesday, October 22, 2024. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and inst.

USANA Schedules Third Quarter 2024 Earnings Release and Conference Call

SALT LAKE CITY , Oct. 1, 2024 /PRNewswire/ -- As vibrant melodies of Country Music Month fill the air this October, there is no better time to explore the symphony between our love for music and the pursuit of mental wellness. Country music, with its rich storytelling and emotional resonance, offers more than just a soundtrack to our lives—it serves as a guiding force in achieving mental well-being, according to Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA).

USANA Executive Chairman Kevin Guest Celebrates Country Music Month, Mental Balance

40 Gold, 33 Silver, and 26 Bronze won SALT LAKE CITY , Sept. 19, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. would like to congratulate all 265 sponsored USANA Athletes who competed at the 2024 Summer Olympic and Paralympic Games in Paris.

USANA-Sponsored Olympic and Paralympic Athletes Take Home 99 Combined Medals

SALT LAKE CITY , Sept. 3, 2024 /PRNewswire/ -- Entrepreneurs play a critical role in driving innovation, economic growth, and stability, according to Kevin Guest, executive chairman at USANA Health Sciences, a global leader in health and wellness products.

USANA Executive Chairman Kevin Guest Celebrates Entrepreneurs in Today's Business World

SALT LAKE CITY , Aug. 19, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. has recently added two new products to its line of high-quality, science-based products. Celavive Resurfacing Serum blends powerful, clinically proven ingredients formulated to visibly transform the look of your skin.

USANA Launches New, Innovative Skincare and Protein Products Resurfacing Serum and Whey Protein Isolate up the game for USANA

SALT LAKE CITY , Aug. 1, 2024 /PRNewswire/ -- Inspired by Olympians, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), is urging all to dig deep into their inner strength to excel in their personal and professional life. "Today's elite athlete shows tremendous discipline, resilience, determination and grit, all traits that develop winners in life," Guest said.

USANA Executive Chairman Kevin Guest Shares 7 Steps to Soar Like Olympians

USANA Health Sciences, Inc. (NYSE:USNA ) Q2 2024 Earnings Conference Call July 24, 2024 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President & CEO Douglas Hekking - CFO Brent Neidig - Chief Commercial Officer Walter Noot - COO Conference Call Participants Anthony Lebiedzinski - Sidoti & Company Linda Bolton-Weiser - D.A. Davidson Doug Lane - Water Tower Research Operator Hello, and welcome to the USANA Health Sciences Second Quarter Earnings Call.

USANA Health Sciences, Inc. (USNA) Q2 2024 Earnings Call Transcript

USANA Health Sciences (USNA) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.89 per share a year ago.

USANA Health Sciences (USNA) Misses Q2 Earnings and Revenue Estimates

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2024. Key Financial & Operating Results Second quarter net sales were $213 million versus $238 million during Q2 2023. Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023. Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $.

USANA Health Sciences Reports Second Quarter 2024 Results

Sponsored athletes to represent 10 nations across multiple disciplines in Paris SALT LAKE CITY , July 17, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. wishes the very best for the 284 sponsored USANA Athletes who earned their spot at the 2024 Summer Olympic and Paralympic Games in Paris. These athletes represent 10 nations including Canada, China, France, Indonesia, Italy, Mexico, Malaysia, South Korea, Spain, and the United States.

284 USANA-Sponsored Athletes in 2024 Summer Olympic and Paralympic Games

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter 2024 results will be released after the close of market on Tuesday, July 23, 2024. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and instit.

USANA Schedules Second Quarter 2024 Earnings Release and Conference Call

CEO Jim Brown visits the country to meet the local team, leaders, and share long-term vision for the market NEW DELHI , July 8, 2024 /PRNewswire/ -- Reaching one million active customers is the first step towards USANA Health Sciences, Inc.'s mission of building the healthiest family on earth—making international expansion a critical initiative. In late 2023, USANA opened its business to the India market, and for the first time since that opening, USANA's President and CEO Jim Brown will be visiting the country.

USANA Executives Make First Visit to New India Market

Zoetis

Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?

USNA vs. ZTS: Which Stock Is the Better Value Option?

SALT LAKE CITY , July 1, 2024 /PRNewswire/ -- Throughout July, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), is emphasizing boosting social connections during "Social Wellness Month." Social wellness—the ability to form meaningful relationships and interact positively with others—not only enhances our emotional well-being but also significantly impacts our overall health.

USANA Executive Chairman Kevin Guest Encourages Connections with July's "Social Wellness Month"

Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?

USNA or ZTS: Which Is the Better Value Stock Right Now?

PWHL Toronto forward also led the league in goals SALT LAKE CITY , June 18, 2024 /PRNewswire/ -- USANA would like to congratulate one of their sponsored athletes, Natalie Spooner on her Most Valuable Player award from the Professional Women's Hockey League. Natalie is the first ever Billie Jean King MVP winner for the league in its inaugural season.

USANA Athlete Natalie Spooner Wins Inaugural PWHL MVP Award

SALT LAKE CITY , June 3, 2024 /PRNewswire/ -- For the month of June, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), is emphasizing the significance of "Rebuild Your Life" month as an opportunity for individuals to take proactive steps toward healthier, more fulfilling lives. Drawing upon life experiences and guiding principles in his acclaimed book, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony, Guest introduces a tapestry of remarkable stories that underscore the power of positive change.

USANA Executive Chairman Kevin Guest Encourages Self-Renewal with June's "Rebuild Your Life Month"

AFC Bournemouth and USANA join forces to empower local youngsters with breakfast club initiatives SALT LAKE CITY , May 30, 2024 /PRNewswire/ -- USANA Health Sciences and its USANA Foundation have teamed up with English soccer club AFC Bournemouth to support local youth in the Bournemouth area. This collaboration expands upon existing community endeavours by the club, like the Holiday Activity Fund, which provides vital support to children and families.

News for USANA Health Sciences Stock (USNA)